![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Jiangsu Chengxin Pharmaceutical Co., Ltd. Qidong Cn, based in China, is a pharmaceutical company.
One of their significant offerings is Praziquantel, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2014-371 - Rev 01
This Chemical Type CEP, issued on April 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 855 associated with this CEP further emphasizes